Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,330 | -24,110 | -18,856 | -11,125 | -4,911 |
| Depreciation Amortization | 53 | 1,080 | 457 | 267 | 96 |
| Accounts payable and accrued liabilities | -403 | 1,045 | 430 | 350 | 578 |
| Other Working Capital | -36 | 14,560 | 15,452 | 15,996 | 15,399 |
| Other Operating Activity | 4,313 | 5,005 | 4,384 | 1,561 | -117 |
| Operating Cash Flow | $-6,403 | $-2,420 | $1,867 | $7,049 | $11,045 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -47,006 | -61,502 | -44,093 | -36,693 | -19,484 |
| PPE Investments | -133 | -40 | -18 | -5 | N/A |
| Other Investing Activity | 2 | -118 | 0 | 0 | 0 |
| Investing Cash Flow | $-47,137 | $-61,660 | $-44,111 | $-36,698 | $-19,484 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -9,000 | -750 | N/A | -1 |
| Common Stock Issued | 53,549 | 191 | 180 | 12 | N/A |
| Other Financing Activity | -1 | 86,069 | 87,019 | 26,377 | 7,713 |
| Financing Cash Flow | $53,548 | $77,260 | $86,449 | $26,389 | $7,712 |
| Beginning Cash Position | 23,179 | 10,000 | 10,009 | 10,009 | 10,009 |
| End Cash Position | 23,187 | 23,170 | 54,214 | 6,749 | 9,282 |
| Net Cash Flow | $8 | $13,170 | $44,205 | $-3,260 | $-727 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,403 | -2,420 | 1,867 | 7,049 | 11,045 |
| Capital Expenditure | -133 | -49 | -18 | -5 | N/A |
| Free Cash Flow | -6,536 | -2,469 | 1,849 | 7,044 | 11,045 |